Event Details
22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
Dec 13, 2024 7:30 AM PST
Title: PALISADE: A Phase 3 Study to Assess the Efficacy and Safety of Plozasiran in Adults with Genetically or Clinically-Defined Familial Chylomicronemia Syndrome (FCS) at high risk of Acute Pancreatitis (AP)
Date/Time: December 13, 2024, 7:30-9:00 a.m. PST
Presenter: Nick Leeper and Ira Goldberg
Session: Poster and Abstract Oral Presentation Session
Supporting Materials
WCIRDC 2024 Oral 1.3 MB
WCIRDC 2024 Poster 1 MB